Log in
Enquire now

List of Boston Biomedical Research Institute patents

List of Boston Biomedical Research Institute patents
List of J2 Global patents
List of Natco Pharma patents
List of Geno patents
List of SBIR/STTR awards granted to III-N Technology, Inc
Investors in TradingView
Patents where
Current Assignee
Name
is
‌
Boston Biomedical Research Institute
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7413884 Immunological control of β-amyloid levels in vivo

Patent 7413884 was granted and assigned to Boston Biomedical Research Institute on August, 2008 by the United States Patent and Trademark Office.

‌
Boston Biomedical Research Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
7413884
August 19, 2008
‌
US Patent 7709216 Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death

Patent 7709216 was granted and assigned to Boston Biomedical Research Institute on May, 2010 by the United States Patent and Trademark Office.

‌
Boston Biomedical Research Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
7709216
May 4, 2010
‌
US Patent 7906626 Immunological control of β-amyloid levels in vivo

Patent 7906626 was granted and assigned to Boston Biomedical Research Institute on March, 2011 by the United States Patent and Trademark Office.

‌
Boston Biomedical Research Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
7906626
March 15, 2011
‌
US Patent 7749966 Immunological modulation of insulin-like growth factor 1 for cancer prevention/treatment and prolonging longevity

Patent 7749966 was granted and assigned to Boston Biomedical Research Institute on July, 2010 by the United States Patent and Trademark Office.

‌
Boston Biomedical Research Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
7749966
July 6, 2010
‌
US Patent 7968527 Inhibition of FGF signaling

Patent 7968527 was granted and assigned to Boston Biomedical Research Institute on June, 2011 by the United States Patent and Trademark Office.

‌
Boston Biomedical Research Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
7968527
June 28, 2011
‌
US Patent 7553832 Methods and compositions for specific inhibition of protein splicing by small molecules

Patent 7553832 was granted and assigned to Boston Biomedical Research Institute on June, 2009 by the United States Patent and Trademark Office.

‌
Boston Biomedical Research Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
7553832
June 30, 2009
‌
US Patent 7612043 Method of reducing or inhibiting ObR signaling using a leptin antagonist consisting of SEQ id No: 2

Patent 7612043 was granted and assigned to Boston Biomedical Research Institute on November, 2009 by the United States Patent and Trademark Office.

‌
Boston Biomedical Research Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
7612043
November 3, 2009
‌
US Patent 7407929 Leptin peptide antagonists

Patent 7407929 was granted and assigned to Boston Biomedical Research Institute on August, 2008 by the United States Patent and Trademark Office.

‌
Boston Biomedical Research Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
7407929
August 5, 2008
‌
US Patent 8759098 Method for cloning pluripotent stem cells

‌
Boston Biomedical Research Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
8759098
June 24, 2014
‌
US Patent 8058228 Leptin peptide antagonists

Patent 8058228 was granted and assigned to Boston Biomedical Research Institute on November, 2011 by the United States Patent and Trademark Office.

‌
Boston Biomedical Research Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
8058228
November 15, 2011
‌
US Patent 6872554 Immunological control of β-amyloid levels in vivo

Patent 6872554 was granted and assigned to Boston Biomedical Research Institute on March, 2005 by the United States Patent and Trademark Office.

‌
Boston Biomedical Research Institute
United States Patent and Trademark Office
United States Patent and Trademark Office
6872554
March 29, 2005
11 results
0 selected
11 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us